NAPSR Cnpr Correct answers latest update
Primary Care
checkups and general health issues
Secondary Care
specialized outpatient consults
Tertiary Care
inpatient
biotechnology industry
newest most advanced area; gene research, genetically altered drugs, and molecular biology
managed care
eliminate inefficiencies; developed HMO's and PBM's (act as intermediary btwn pharma companies
and large drug purchasers
PBM's strongest tool
mail or phone order processing
FDA
regulates the intro of new drugs; safety and effectiveness of new drugs and requires companies to
follow good manufacturing practices (GMP)
FDA's average review time for new drug
18 months
marketing of prescription drugs 2 categories
professional physician promos; and direct to consumers advertising (more growth with ads)
Regional Managers
supervise regions (RM's)
Districts and territories
Districts are supervised by district manager; and territories staffed by territory reps
Most effective method for grabbing market share
use comparative selling
my primary target
physician
Full service pharm companies 3 functional categories
, R & D; Manufacturing and Operations; Marketing and Sales
Pharm high level of growth due to:
Research and Development
approvable letter
letter sent by FDA to applicant saying whether or not product meets requirements
Fast track drugs
approval for drugs that don't meet unmet medical needs for those with serious or life-threatening
conditions
indication
the exact cause or purpose for whether drug is approved by the FDA to be prescribed
off label
usage of med for purpose other than appear on labelingf
study protocol
general design and features of a trial
clinical pharacology
the study of the effects and movements of drugs in the human body
Drugs 2 categories:
prescription and non-prescription drugs
every drug has 3 names:
chemical name (molecular structure of drug); generic; and trade, proprietary name (sold under trade
name)
When new compound shows promise its usually modified many times to optimize:
intended site(selectivity); site (affinity); strength (potency); and effectiveness (efficacy)
Entire drug review process from lab to medicine cabinet is :
10 years; only about 1 in 5,000 is approved
Pharmacokinetics
what the body does to a drug
Drug administration (routes)
orally (mouth); vein (intravenously); muscle (intramuscular); intrathecally (spinal cord); ocular (eye);
cutaneously (skin); transdermal (body wide )
Primary Care
checkups and general health issues
Secondary Care
specialized outpatient consults
Tertiary Care
inpatient
biotechnology industry
newest most advanced area; gene research, genetically altered drugs, and molecular biology
managed care
eliminate inefficiencies; developed HMO's and PBM's (act as intermediary btwn pharma companies
and large drug purchasers
PBM's strongest tool
mail or phone order processing
FDA
regulates the intro of new drugs; safety and effectiveness of new drugs and requires companies to
follow good manufacturing practices (GMP)
FDA's average review time for new drug
18 months
marketing of prescription drugs 2 categories
professional physician promos; and direct to consumers advertising (more growth with ads)
Regional Managers
supervise regions (RM's)
Districts and territories
Districts are supervised by district manager; and territories staffed by territory reps
Most effective method for grabbing market share
use comparative selling
my primary target
physician
Full service pharm companies 3 functional categories
, R & D; Manufacturing and Operations; Marketing and Sales
Pharm high level of growth due to:
Research and Development
approvable letter
letter sent by FDA to applicant saying whether or not product meets requirements
Fast track drugs
approval for drugs that don't meet unmet medical needs for those with serious or life-threatening
conditions
indication
the exact cause or purpose for whether drug is approved by the FDA to be prescribed
off label
usage of med for purpose other than appear on labelingf
study protocol
general design and features of a trial
clinical pharacology
the study of the effects and movements of drugs in the human body
Drugs 2 categories:
prescription and non-prescription drugs
every drug has 3 names:
chemical name (molecular structure of drug); generic; and trade, proprietary name (sold under trade
name)
When new compound shows promise its usually modified many times to optimize:
intended site(selectivity); site (affinity); strength (potency); and effectiveness (efficacy)
Entire drug review process from lab to medicine cabinet is :
10 years; only about 1 in 5,000 is approved
Pharmacokinetics
what the body does to a drug
Drug administration (routes)
orally (mouth); vein (intravenously); muscle (intramuscular); intrathecally (spinal cord); ocular (eye);
cutaneously (skin); transdermal (body wide )
